Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.44 USD | +1.53% | +2.49% | +19.28% |
May. 08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
May. 07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.28% | 3.21B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.39% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- Ideaya Biosciences Insider Sold Shares Worth $2,627,618, According to a Recent SEC Filing